JarenLernerMD

Heme/onc fellow

Dr. Lerner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Louisiana State University (Shreveport)Fellowship, Hematology and Medical Oncology, 2022 - 2025
Ochsner LSU Health Shreveport - Academic Medical CenterResidency, 2025
Eisenhower Medical CenterResidency, Internal Medicine, 2018 - 2021
Ross University School of MedicineClass of 2018

PubMed

3 citations
Advanced papillary thyroid carcinoma responding to nivolumab
Miguel Michel Ocampo, Jaren Lerner, Shawnt Tosonian, Constantin A Dasanu
Journal of Oncology Pharmacy Practice. 2021-03-01
5 citations
Bluish-gray fingernail discoloration due to the use of nivolumab:
Miguel Michel Ocampo, Jaren Lerner, Constantin A Dasanu
Journal of Oncology Pharmacy Practice. 2021-03-01
3 citations
Management and clinical outcomes in uterine malignant mixed Müllerian tumor: Lessons from a single-institution series:
Constantin A Dasanu, Andrew S Iskandar, Andrew Hwang, Wesley T. Kerr, Stephanie Farrell
Journal of Oncology Pharmacy Practice. 2020-04-01

Abstracts/Posters

Age-related clinicopathologic features and survival in papillary serous uterine cancer patients older and younger than 70: An exploratory analysis of a series of conse...
Jaren Lerner, Miguel Michel, Andrew Samir Iskandar, Jaspreet Kaur, Shahaf Tuler, Stephanie Farrell, Steven C. Plaxe, Constantin Dasanu, Journal of Clinical Oncology, 5/25/2020